United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of the company’s stock in a transaction dated Thursday, April 9th. The shares were sold at an average price of $577.89, for a total value of $5,778,900.00. Following the sale, the chief financial officer owned 18,876 shares in the company, valued […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of United Therapeutics stock in a transaction that occurred on Thursday, April 9th. The shares were sold at an average price of $577.89, for a total value of $5,778,900.00. Following the sale, the chief financial officer directly owned 18,876 shares in […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of the stock in a transaction dated Monday, April 6th. The stock was sold at an average price of $558.40, for a total value of $5,584,000.00. Following the transaction, the chief financial officer directly owned 18,876 shares in the company, valued […]

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CFO Kory James Wentworth sold 2,500 shares of Entrada Therapeutics stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $12.95, for a total transaction of $32,375.00. Following the completion of the sale, the chief financial officer directly owned 119,010 […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of the firm’s stock in a transaction dated Thursday, March 26th. The shares were sold at an average price of $535.90, for a total value of $5,359,000.00. Following the sale, the chief financial officer owned 18,876 shares in the company, valued […]